ImCheck Therapeutics

@imcheck_therapeutics

Marseille, Provence-Alpes-Cote d'Azur

Biotechnology

Overview

About ImCheck Therapeutics

ImCheck Therapeutics an Ipsen company is headquartered in Marseille-France. ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators.

Headquarters

Marseille, Provence-Alpes-Cote d'Azur

Website

http://imchecktherapeutics.com

Company Size

11-50 employees

Industry

Biotechnology

Company Type

Privately Held

Founded

2025

Specialties

antibodies, immuno-oncology, Immune checkpoint Modulators, Auto-immunity, innate immunity, oncology, cancer, precision-based medicine, adaptative immunity, EVICTIONtrial, ICT01, and gamma-deltaTcells